Bone mineral density and bone turnover in non-cirrhotic patients with chronic hepatitis C and sustained virological response to antiviral therapy with peginterferon-alfa and ribavirin. [electronic resource]
- Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Jun 2014
- 1709-15 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1433-2965
10.1007/s00198-014-2663-z doi
Absorptiometry, Photon--methods Adult Antiviral Agents--pharmacology Biomarkers--blood Bone Density--drug effects Bone Diseases, Metabolic--physiopathology Bone Remodeling--drug effects Case-Control Studies Drug Therapy, Combination Female Femur Neck--physiopathology Hepatitis C, Chronic--complications Humans Interferon-alpha--pharmacology Lumbar Vertebrae--physiopathology Male Middle Aged Polyethylene Glycols--pharmacology Prospective Studies Receptors, Tumor Necrosis Factor, Type I--blood Recombinant Proteins--pharmacology Ribavirin--pharmacology Tumor Necrosis Factor Decoy Receptors--blood Young Adult